A Phase 1/2A, Single Dose Study Of PF-04383119 In Japanese Patients With Moderate To Severe Pain From Osteoarthritis Of The Knee

NCT00669409 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

83

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis, Knee

Interventions

DRUG: PF-04383119 (tanezumab)
DRUG: PF-04383119 (tanezumab)
DRUG: PF-04383119 (tanezumab)
DRUG: PF-04383119 (tanezumab)
DRUG: PF-04383119 (tanezumab)
DRUG: PF-04383119 (tanezumab)

Sponsor

Pfizer